Discover the top 25 companies transforming the injection pen market, including Novo Nordisk A/S, Eli Lilly and Company, Sanofi, and other industry leaders. Backed by a market projected to grow from $47.0B to $74.1B by 2030 at a CAGR of 7.9%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.
Download PDF Brochure:“Click Here”
Spotlights on the Industry’s Top Injection Pen Companies
Novo Nordisk A/S
Novo Nordisk is a global healthcare leader specializing in diabetes care and other serious chronic diseases. The company is a pioneer in the injection pen market, offering an extensive portfolio of delivery systems including the FlexPen, FlexTouch, and the smart NovoPen 6 and NovoPen Echo Plus. Their devices are designed to enhance patient adherence through features like low injection force, audible dose confirmation, and digital dose memory, maintaining a dominant position in the global insulin delivery landscape.
Eli Lilly and Company
Eli Lilly and Company is a prominent pharmaceutical firm with a century-long legacy in insulin production and delivery innovation. The company’s proprietary KwikPen platform is a cornerstone of its injectable portfolio, used for delivering major therapies such as Humalog, Basaglar, and the high-demand obesity treatment Zepbound. Lilly continues to advance its market presence through the development of the Tempo Pen and integrated digital health tools aimed at simplifying the administration of complex biologic therapies.
Sanofi
Sanofi is a leading global biopharmaceutical company that provides comprehensive solutions for diabetes management. Its injection pen portfolio features the SoloStar disposable pen, used for its blockbuster insulin Lantus, and the AllStar PRO reusable pen designed for high-quality, sustainable insulin delivery. Sanofi distinguishes itself by offering a range of devices, including the JuniorSTAR for half-unit dosing, to meet the diverse needs of patients requiring precise glycemic control.
Ypsomed Holding AG
Based in Switzerland, Ypsomed is a leading developer and manufacturer of injection systems for self-medication. The company offers a versatile platform of pen injectors, such as the YpsoPen, UnoPen, and the spring-driven YpsoFlow, available in both reusable and disposable formats. Ypsomed’s focus on modular design and technical excellence allows for rapid customization for pharmaceutical partners, supporting a wide range of therapies including insulin, GLP-1s, and other peptides.
Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a global medical technology leader that provides critical infrastructure for the injection pen market. While widely recognized for its market-leading BD Ultra-Fine and Micro-Fine pen needles, the company also offers the Vystra disposable pen injector platform. BD’s expertise in ergonomics and high-volume manufacturing enables pharmaceutical companies to accelerate the commercialization of injectable drugs through validated, patient-centric delivery systems.
Merck KGaA
Merck KGaA is a science and technology innovator that contributes to the injection pen market through its expertise in drug delivery for chronic conditions. The company focuses on enhancing the patient experience by integrating its therapeutic offerings with user-friendly injection devices. Merck KGaA emphasizes quality and precision in its delivery systems to ensure the safe and effective administration of its specialist biopharmaceutical products.
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that utilizes advanced injection pen technology to deliver its portfolio of treatments for cardiovascular, renal, and metabolic diseases. By providing intuitive, pre-filled pen devices for its injectable medications, AstraZeneca aims to improve treatment outcomes and patient compliance. The company focuses on integrating device design with clinical efficacy to maintain its competitive edge in the chronic disease management sector.
Owen Mumford
Owen Mumford is a major medical device manufacturer specializing in the design and production of innovative drug delivery systems. The company is known for its range of pen injectors that prioritize ease of use and safety for patients managing long-term conditions. Owen Mumford collaborates with global pharmaceutical partners to provide customizable delivery solutions that reduce needle phobia and improve the overall self-injection experience.
Haselmeier
Haselmeier, a part of the medmix group, is a specialist in the development and manufacture of innovative self-injection systems. The company provides a comprehensive range of subcutaneous drug delivery devices, including reusable and disposable pens that are highly customizable. Haselmeier’s focus on precision engineering and high-quality design makes it a preferred partner for biopharmaceutical firms looking to differentiate their injectable therapies in a competitive market.
Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries is a leading multinational specialty generic pharmaceutical company based in India. In the injection pen market, Sun Pharma focuses on providing affordable and accessible injectable treatments, including insulin and other specialty drugs, delivered via user-friendly pen devices. The company leverages its extensive manufacturing capabilities to support the growing demand for self-administered therapies in both emerging and developed markets.
Pfizer Inc.
Pfizer Inc. is one of the world’s premier biopharmaceutical companies, utilizing injection pen technology to support its diverse portfolio of injectable therapies. Pfizer focuses on patient-centric device design to ensure that its life-saving medications are administered safely and accurately. The company continues to invest in delivery innovation to enhance the efficacy of its treatments for oncology, rare diseases, and inflammatory conditions.
Biocon
Biocon is a leading global biopharmaceutical company based in India that specializes in the development of biosimilars, particularly in the field of diabetes. The company provides a range of insulin delivery solutions, including pre-filled and reusable pens, designed to offer high-quality alternatives to branded biologics. Biocon’s focus on affordability and clinical excellence has made it a significant player in the global insulin injection market.
Lupin
Lupin is an innovation-led transnational pharmaceutical company that has expanded its presence in the injectable drug delivery market. The company develops and markets various injectable therapies, utilizing pen injectors to improve patient convenience and adherence. Lupin’s commitment to providing cost-effective and high-quality respiratory and diabetes treatments through modern delivery systems strengthens its position in the specialty medicines sector.
Wockhardt Ltd.
Wockhardt is a global pharmaceutical and biotechnology company with a strong focus on the diabetes market. The company manufactures a variety of insulin products and provides them in easy-to-use pen delivery systems. Wockhardt’s expertise in fermentation and bioprocessing allows it to produce high-quality insulin analogs, which are distributed globally to meet the needs of patients requiring reliable self-injection tools.
Medtronic
Medtronic is a global leader in medical technology, primarily known for its advanced diabetes management solutions, including insulin pumps and continuous glucose monitoring (CGM) systems. While a major force in automated delivery, Medtronic also contributes to the injection pen ecosystem through its digital health integrations and data-driven insights. The company focuses on connecting delivery devices with monitoring technology to provide a holistic approach to patient care.
Gerresheimer AG
Gerresheimer is a leading global partner to the pharma and healthcare industry, specializing in the manufacture of specialty packaging and drug delivery devices. The company produces high-quality glass and plastic components essential for injection pens, as well as providing contract manufacturing for complex delivery systems. Gerresheimer’s focus on sustainability and technical innovation ensures the reliable production of pre-fillable syringes and pen components for global pharmaceutical brands.
Shaily Engineering Plastics Ltd.
Shaily Engineering Plastics is an Indian-based manufacturer specializing in high-precision injection molded plastic components and finished devices. The company has established itself as a key supplier in the medical device sector, specifically in the production of complex drug delivery systems like insulin pens. Shaily’s commitment to international quality standards and advanced engineering makes it a critical manufacturing partner for global healthcare companies.
SHL Medical AG
SHL Medical is a world-leading provider of advanced drug delivery systems, particularly autoinjectors and pen injectors. The company specializes in creating innovative solutions for high-viscosity drugs and large-volume injections, supporting the growing biologics market. SHL Medical provides end-to-end services, from design and development to final assembly, ensuring that pharmaceutical partners receive robust and patient-friendly delivery platforms.
Emperra GmbH E-Health Technologies
Emperra is a digital health company that specializes in integrated diabetes management systems. Their flagship innovation, the ESYSTA system, features smart insulin pens that automatically transmit dosing data to a digital platform. Emperra focuses on bridging the gap between mechanical delivery and digital monitoring, providing patients and healthcare providers with actionable data to optimize insulin therapy and improve clinical outcomes.
Nemera France SAS
Nemera is a world leader in the design, development, and manufacturing of drug delivery devices across multiple therapeutic areas. In the injection pen market, Nemera offers proprietary platforms and contract manufacturing services for parenteral delivery. The company emphasizes a “patient-first” approach, conducting extensive human factors studies to ensure its devices are intuitive, safe, and effective for self-administration.
Jiangsu Delfu Medical Device Co., Ltd.
Jiangsu Delfu Medical Device is a Chinese manufacturer specializing in the production of medical instruments and drug delivery devices. The company provides a variety of injection pens and safety needles aimed at the diabetes care and hormone therapy markets. Delfu focuses on providing cost-effective manufacturing solutions and expanding its presence in the international market through high-quality, standardized medical products.
Solteam Medical
Solteam Medical is a specialist manufacturer of precision medical components and assemblies, with a focus on drug delivery devices like pen injectors. The company leverages its expertise in injection molding and automated assembly to support pharmaceutical companies in bringing reliable delivery systems to market. Solteam Medical prioritizes quality control and technical innovation to meet the rigorous demands of the global healthcare industry.
Phillips-Medisize
Phillips-Medisize, a Molex company, is a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical and medical device industries. The company specializes in the design and production of complex drug delivery devices, including connected injection pens. Phillips-Medisize integrates electronics and digital connectivity into mechanical delivery systems, helping partners develop “smart” devices that improve patient engagement and data tracking.
Stevanato Group
Stevanato Group is a global provider of drug containment, delivery, and diagnostic solutions to the pharmaceutical industry. The company offers a wide range of services, from the production of glass cartridges for injection pens to the development of sophisticated pen injector platforms. Stevanato’s integrated approach combines high-quality primary packaging with advanced device technology, supporting the entire lifecycle of injectable drug products.
Wanhai Medical Instruments Co., Ltd.
Wanhai Medical Instruments is a professional manufacturer based in China, focused on the production of insulin delivery systems and other medical consumables. The company provides a range of disposable and reusable insulin pens designed for simplicity and ease of use. Wanhai Medical emphasizes affordable healthcare solutions and utilizes modern production facilities to supply high-quality delivery devices to both domestic and international markets.
Download PDF Brochure:“Click Here”
